Document is current

Any future updates will be listed below

Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trial

Crossref DOI link: https://doi.org/10.1038/s41392-025-02153-7

Published Online: 2025-02-18

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark